Edit |   |
---|---|
Antigenic Specificity | CD33, Human (Vadastuximab biosimilar) |
Clone | Vadastuximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD33 Recombinant Antibody (Vadastuximab). Vadastuximab talirine or SGN-CD33A is an antibody-drug conjugate or ADC directed to CD33 or Siglec-3 is a transmembrane receptor expressed on cells of myeloid lineage. The trial drug, being developed by Seattle Genetics and currently in clinical trials, is designed for the treatment of acute myeloid leukemia (AML). |
Immunogen | n/a |
Other Names | Anti-CD33 Recombinant Antibody, Research Grade Vadastuximab, Anti-Human CD33 Recombinant Antibody(Vadastuximab), h2H12ec, Antibody Drug Analogues, Monoclonal Antibody, YR1410, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1436390-63-4 |
Catalog # | YR1410 |
Price | please inquire |
Order / More Info | CD33, Human (Vadastuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |